We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 191

Federal Circuit affirms Commission decision in Inv. No. 337-TA-655
  • McDermott Will & Emery
  • USA
  • October 12 2011

On October 11, 2011, the Federal Circuit, by a 2-1 majority in TianRui Group Co. v. Int’l Trade Comm’n, No. 2010-1395, affirmed the Commission’s ruling in Inv. No. 337-TA-655, In the Matter of Certain Cast Steel Railway Wheels, Processes for Manufacturing or Relating to Same and Certain Products Containing Same


Federal Circuit Rejects ITC’s Authority over Intangible Articles
  • McDermott Will & Emery
  • USA
  • April 28 2016

The US Court of Appeals for the Federal Circuit denied a request for rehearing en banc in ClearCorrect Operating v. Int'l Trade Comm'n, (IP Update


Federal Circuit ruling clears way for approval of generic version of Fentora
  • McDermott Will & Emery
  • USA
  • March 29 2013

Addressing allegations of patent infringement by a generic version of Fentora, the U.S. Court of Appeals for the Federal Circuit reversed in


Obviousness-type double patenting requires a reason to modify with a reasonable expectation of success
  • McDermott Will & Emery
  • USA
  • October 31 2012

Addressing the issue of obviousness-type double patenting, the U.S. Court of Appeals for the Federal Circuit reaffirmed its earlier rulings that obviousness must be judged by whether the differences in subject matter between the new claim and the earlier claim are patentably distinct


New complaint filed by Furuno names Honeywell and Skyforce as proposed respondents
  • McDermott Will & Emery
  • USA
  • October 4 2011

The ITC received a new complaint on September 30, 2011 filed on behalf of Furuno Electric Co. Ltd. and Furuno USA Inc


Generics challenge to Crestor patent fails
  • McDermott Will & Emery
  • USA
  • January 31 2013

In a case involving multiple defendants seeking to sell generic versions of the drug rosuvastatin calcium, currently marketed as Crestor, the U


Court determines RAND rate for standard-essential patents
  • McDermott Will & Emery
  • USA
  • May 31 2013

The U.S. District Court for the Western District of Washington became the first U.S. court to set fair, reasonable and non-discriminatory (FRAND or


Commission issues final determination on remedy and bond in Inv. No. 337-TA-567
  • McDermott Will & Emery
  • USA
  • July 18 2011

On July 15, the Commission issued its final determination finding a violation of Section 337 and issuing a general exclusion order and cease and desist orders in Inv. No. 337-TA-567, Certain Foam Footwear


New target date set in i Inv. No. 337-TA-747
  • McDermott Will & Emery
  • USA
  • April 4 2011

ALJ E. James Gildea issued an order on April 4, 2011 amending the target date and resetting the procedural schedule in Inv. No. 337-TA-747, Certain Products Containing Interactive Program Guide and Parental Controls Technology, due to the ongoing events in Japan


ALJ Rogers denies motion for termination based on a consent order in 337-TA-723
  • McDermott Will & Emery
  • USA
  • October 5 2010

ALJ Rogers denied a renewed motion for termination based on entry of a consent order filed by respondents Mipo Science and Technology Co., Ltd. and Mipo Technology Ltd. (collectively “Mipo”) on September 30, 2010 in Inv. No. 337-TA-723, Certain Inkjet Cartridges with Printheads and Components Thereof